{{Rsnum
|rsid=13149290
|Gene=ZNF827
|Chromosome=4
|position=145829814
|Orientation=plus
|GMAF=0.416
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ZNF827
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 63.3 | 36.7 | 0.0
| HCB | 4.4 | 24.8 | 70.8
| JPT | 6.2 | 23.9 | 69.9
| YRI | 63.2 | 29.2 | 7.6
| ASW | 63.2 | 29.8 | 7.0
| CHB | 4.4 | 24.8 | 70.8
| CHD | 2.8 | 23.9 | 73.4
| GIH | 27.7 | 47.5 | 24.8
| LWK | 53.2 | 42.2 | 4.6
| MEX | 17.2 | 48.3 | 34.5
| MKK | 50.6 | 42.9 | 6.4
| TSI | 54.1 | 37.8 | 8.2
| HapMapRevision=28
}}[[rs13149290]] is one of seven SNPs found in a combined study of over 1,000 patients to be associated with increased risk for [[prostate cancer]]. The risk allele for this SNP is (C); and while the odds ratio was not specifically reported, the probability of false significance (not permuted though) was given as p=2.5 x 10e-5, using a dominant model of risk.{{PMID|18073375}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}